Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga V Matveeva

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Reviews in Medical Virology|September 14, 2018
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic virusesOlga V Matveeva, Peter M Chumakov
Cancers|December 9, 2020
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic VirotherapyOlga V Matveeva, Svetlana A Shabalina
Plos One|June 22, 2018
Sequence characteristics define trade-offs between on-target and genome-wide off-target hybridization of oligoprobesOlga V Matveeva, Aleksey Y Ogurtsov, Nafisa N Nazipova, et al.
Frontiers in Genetics|September 7, 2012
Optimized models for design of efficient miR30-based shRNAsOlga V Matveeva, Nafisa N Nazipova, Aleksey Y Ogurtsov, et al.
Molecular Therapy Oncolytics|December 8, 2015
Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiencyOlga V Matveeva, Zong S Guo, Svetlana A Shabalina, et al.
Frontiers in Veterinary Science|June 20, 2018
Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)Galina V Ilyinskaya, Elena V Mukhina, Alesya V Soboleva, et al.
Genome Announcements|August 13, 2016
Complete Genome Sequence of the Oncolytic Sendai virus Strain MoscowSergei S Zainutdinov, Artem Y Tikunov, Olga V Matveeva, et al.
Oncolytic Virotherapy|August 3, 2019
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypesSergei S Zainutdinov, Galina V Kochneva, Sergei V Netesov, et al.
Nucleic Acids Research|October 5, 2002
Artificial neural network prediction of antisense oligodeoxynucleotide activityMichael C Giddings, Atul A Shah, Sue Freier, et al.
Molecular Therapy Oncolytics|December 8, 2015
Oncolysis by paramyxoviruses: preclinical and clinical studiesOlga V Matveeva, Zong S Guo, Vyacheslav M Senin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Reviews in Medical Virology|September 14, 2018
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic virusesOlga V Matveeva, Peter M Chumakov
Cancers|December 9, 2020
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic VirotherapyOlga V Matveeva, Svetlana A Shabalina
Plos One|June 22, 2018
Sequence characteristics define trade-offs between on-target and genome-wide off-target hybridization of oligoprobesOlga V Matveeva, Aleksey Y Ogurtsov, Nafisa N Nazipova, et al.
Frontiers in Genetics|September 7, 2012
Optimized models for design of efficient miR30-based shRNAsOlga V Matveeva, Nafisa N Nazipova, Aleksey Y Ogurtsov, et al.
Molecular Therapy Oncolytics|December 8, 2015
Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiencyOlga V Matveeva, Zong S Guo, Svetlana A Shabalina, et al.
Frontiers in Veterinary Science|June 20, 2018
Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)Galina V Ilyinskaya, Elena V Mukhina, Alesya V Soboleva, et al.
Genome Announcements|August 13, 2016
Complete Genome Sequence of the Oncolytic Sendai virus Strain MoscowSergei S Zainutdinov, Artem Y Tikunov, Olga V Matveeva, et al.
Oncolytic Virotherapy|August 3, 2019
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypesSergei S Zainutdinov, Galina V Kochneva, Sergei V Netesov, et al.
Nucleic Acids Research|October 5, 2002
Artificial neural network prediction of antisense oligodeoxynucleotide activityMichael C Giddings, Atul A Shah, Sue Freier, et al.
Molecular Therapy Oncolytics|December 8, 2015
Oncolysis by paramyxoviruses: preclinical and clinical studiesOlga V Matveeva, Zong S Guo, Vyacheslav M Senin, et al.
Pageof 2